AIRNEXIS THERAPEUTICS, INC.

Profile

Company Names

AIRNEXIS THERAPEUTICS, INC.

Addresses

1001 PAGE MILL ROAD, BUILDING 4, SUITE 200B, PALO ALTO, CA 94304

Phone Numbers

(619) 604-7904

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2024

State Incorporated:

DELAWARE

Total Amount Raised:

$62,000,000.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2026-01-09 
$62,000,000.00 
$200,000,000.00 
$138,000,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
EVAN 
 
CAPLAN 
DIRECTOR
RENASANT BIO, INC.   |  AIRNEXIS THERAPEUTICS, INC.
JILL 
 
CARROLL 
DIRECTOR
VASCULOX, INC.   |  TIOMA THERAPEUTICS, INC.   |  ARCELLX, INC.   |  NKARTA, INC.   |  PANDION THERAPEUTICS HOLDCO LLC   |  ODYSSEY THERAPEUTICS, INC.   |  AVALYN PHARMA INC.   |  AIRNEXIS THERAPEUTICS, INC.
ANNA 
 
CHEN 
DIRECTOR
LENGO THERAPEUTICS, INC.   |  EYCONIS, INC.   |  AIRNEXIS THERAPEUTICS, INC.
MARIA 
 
FARDIS 
EXECUTIVE OFFICER, DIRECTOR
LION BIOTECHNOLOGIES, INC.   |  QUANTA THERAPEUTICS, INC.   |  AIRNEXIS THERAPEUTICS, INC.
JAMES 
 
LI 
EXECUTIVE OFFICER, DIRECTOR
AIRNEXIS THERAPEUTICS, INC.
COLIN 
 
WALSH 
DIRECTOR
PEER NETWORKS, INC.   |  CRESCENT CAPITAL III LP   |  VARO MONEY, INC.   |  DEVA PARENT HOLDINGS, INC.   |  ELEVATION ONCOLOGY, INC.   |  AIRNEXIS THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-03-09
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2026-01-09 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#